Matinas Biopharma Holdings (MTNB) Earnings Date & Reports

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MTNB is expected to report earnings to fall 98.49% to -2 cents per share on November 06

Matinas Biopharma Holdings MTNB Stock Earnings Reports

Q3'24

Est.

$-0.03

Q4'24

Missed

by $1.63

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.03

Q4'23

Beat

by $0.01

The last earnings report on April 15 showed earnings per share of -165 cents, missing the estimate of -2 cents. With 19.57K shares outstanding, the current market capitalization sits at 3.03M.

View a ticker or compare two or three

Compare

MTNB